Charter Oak Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.18M Sell
9,826
-1,356
-12% -$157K 0.09% 76
2025
Q4
$1.18M Sell
11,182
-97
-0.9% -$9.11K 0.09% 77
2025
Q3
$947K Sell
11,279
-2,461
-18% -$203K 0.07% 85
2025
Q2
$1.09M Sell
13,740
-182
-1% -$14.5K 0.09% 71
2025
Q1
$1.25M Buy
13,922
+327
+2% +$30.5K 0.11% 59
2024
Q4
$1.35M Buy
13,595
+1,991
+17% +$205K 0.13% 59
2024
Q3
$1.32M Buy
11,604
+390
+3% +$46.3K 0.12% 60
2024
Q2
$1.39M Buy
11,214
+1
+0% +$129 0.14% 56
2024
Q1
$1.48M Buy
11,213
+9
+0.1% +$1.11K 0.16% 54
2023
Q4
$1.22M Buy
11,204
+6
+0.1% +$623 0.15% 56
2023
Q3
$1.15M Sell
11,198
-317
-3% -$34.2K 0.15% 56
2023
Q2
$1.33M Buy
11,515
+432
+4% +$49K 0.17% 57
2023
Q1
$1.18M Sell
11,083
-229
-2% -$24.7K 0.16% 59
2022
Q4
$1.26M Buy
11,312
+106
+0.9% +$10.8K 0.19% 58
2022
Q3
$965K Sell
11,206
-734
-6% -$65.5K 0.15% 61
2022
Q2
$1.09M Sell
11,940
-993
-8% -$88K 0.15% 63
2022
Q1
$1.06M Buy
12,933
+57
+0.4% +$4.49K 0.13% 72
2021
Q4
$987K Buy
12,876
+22
+0.2% +$1.75K 0.11% 76
2021
Q3
$965K Buy
12,854
+1,007
+9% +$76.6K 0.12% 72
2021
Q2
$921K Sell
11,847
-562
-5% -$41.8K 0.12% 74
2021
Q1
$913K Sell
12,409
-60
-0.5% -$4.43K 0.13% 77
2020
Q4
$973K Buy
+12,469
New +$954K 0.15% 65

Other funds holding MRK

Charter Oak Capital Management's MRK Position: Q1 2026 in Review

Charter Oak Capital Management reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $157K and leaving 9,826 shares worth $1.18M. The position accounts for 0.09% of the portfolio, ranked #76.

Charter Oak Capital Management first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.48M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Charter Oak Capital Management held 9,826 shares of Merck worth $1.18M as of Q1 2026.
  • Charter Oak Capital Management sold 1,356 Merck shares in Q1 2026, an estimated $157K.
  • Merck made up 0.09% of Charter Oak Capital Management's portfolio in Q1 2026, its #76 holding.
  • Charter Oak Capital Management first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Charter Oak Capital Management's Merck position peaked at $1.48M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Charter Oak Capital Management's 13F filing for Q1 2026, filed 24 Apr 2026.